STRATEC Biomedical AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution



STRATEC Biomedical AG 

31.10.2012 20:12

Dissemination of a Voting Rights Announcement, transmitted by DGAP - a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.


1. Voting Rights Announcement
Tanja van Dinter, Germany, notified us on October 30, 2012 pursuant to § 21 (1) of the German Securities Trading Act (WpHG) that her share of the voting rights in STRATEC Biomedical AG, Birkenfeld, Germany, ISIN: DE0007289001, exceeded the threshold of 10% on October 24, 2012 and amounted to 10.38% on this date (1,217,953 voting rights).
2. Voting Rights Announcement
Bettina Siegle, Germany, notified us on October 30, 2012 pursuant to § 21 (1) of the German Securities Trading Act (WpHG) that her share of the voting rights in STRATEC Biomedical AG, Birkenfeld, Germany, ISIN: DE0007289001, exceeded the threshold of 10% on October 24, 2012 and amounted to 10.53% on this date (1,235,620 voting rights).
3. Voting Rights Announcement
Hermann Leistner, Germany, notified us on October 30, 2012 pursuant to § 21 (1) of the German Securities Trading Act (WpHG) that his share of the voting rights in STRATEC Biomedical AG, Birkenfeld, Germany, ISIN: DE0007289001, fell below the threshold of 15% on October 24, 2012 and amounted to 10.14% at this date (1,190,456 voting rights). Of these, 9.71% (1,140,000 voting rights) were attributable to him pursuant to § 22 (1) Sentence 1 No. 1 of the German Securities Trading Act (WpHG) via two companies he controls, namely Herdor GmbH & Co. KG, Unterschleißheim, Germany, and Herdor Beteiligungs GmbH, Unterschleißheim, Germany.

4. Voting Rights Announcement
Ralf Leistner, Germany, notified us on October 30, 2012 pursuant to § 21 (1) of the German Securities Trading Act (WpHG) that his share of the voting rights in STRATEC Biomedical AG, Birkenfeld, Germany, ISIN: DE0007289001, exceeded the threshold of 10% on October 24, 2012 and amounted to 10.57% on this date (1,241,010 voting rights).


31.10.2012 DGAP's Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de

 
Language:     English
Company:      STRATEC Biomedical AG
              Gewerbestr. 37
              75217 Birkenfeld
              Germany
Internet:     www.stratec.com
 
End of Announcement DGAP News-Service  




back